Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 17/20 | 0.54 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.54 |
| ▸ | CAPN2 | P17655 | 1/20 | 0.54 |
| ▸ | CTSS | P25774 | 9/20 | 0.52 |
| ▸ | CTSL | P07711 | 5/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | CA5A | P35218 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4041597 | 1.00 | CTSK (0.54) | CTSKCAPN1CAPN2CTSSCTSL | |
| SCHEMBL6209011 | 1.00 | CTSK (0.54) | CTSKCAPN1CAPN2CTSSCTSL | |
| SCHEMBL4041602 | 1.00 | CTSK (0.54) | CTSKCAPN1CAPN2CTSSCTSL | |
| SCHEMBL4037581 | 0.86 | ABCB1 (0.51) | — | |
| SCHEMBL4037583 | 0.86 | ABCB1 (0.51) | — | |
| SCHEMBL4230704 | 0.83 | CTSK (0.54) | CTSKCAPN1CAPN2CTSSCTSL | |
| SCHEMBL4230705 | 0.83 | CTSK (0.54) | CTSKCAPN1CAPN2CTSSCTSL | |
| SCHEMBL4230700 | 0.83 | CTSK (0.54) | CTSKCAPN1CAPN2CTSSCTSL | |
| SCHEMBL2670566 | 0.80 | CAPN1 (0.68) | CTSKCAPN1CAPN2CTSSCTSL | |
| SCHEMBL3086475 | 0.78 | CTSK (0.53) | CTSKCTSSCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546150-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | Amura Therapeutics Limited (GB) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | disclosed |